TELCON RF PHARMACEUTICAL. Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. It operates through the Radio frequency (RF) business division and Pharmaceutical and bio-pharmaceutical business division. The RF business division provides connectors, cable assemblies and components. The Pharmaceutical and bio-pharmaceutical business division offers algicell solution, gud solution, livamax suspension and other drugs. The company was founded on January 8, 1999 and is headquartered in Yongin-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company